id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-D-0226-0010,FDA,FDA-2005-D-0226,FDA,Notice,NAD-Notice of Availability of Data,2006-09-26T04:00:00Z,2006,9,2006-09-21T04:00:00Z,,2008-04-11T23:47:01Z,,0,0,0900006480442005
FDA-2005-D-0226-0011,FDA,FDA-2005-D-0226,Guidance,Supporting & Related Material,GDL-Guidance,2006-09-26T04:00:00Z,2006,9,,,2008-04-11T23:47:02Z,,0,0,0900006480442006
FDA-2005-D-0226-0006,FDA,FDA-2005-D-0226,Guideline,Supporting & Related Material,GDL-Guidance,2006-06-30T04:00:00Z,2006,6,,,2008-04-11T23:47:02Z,,0,0,0900006480441fff
FDA-2005-D-0226-0007,FDA,FDA-2005-D-0226,FDA,Notice,NAD-Notice of Availability of Data,2006-06-30T04:00:00Z,2006,6,2006-06-28T04:00:00Z,,2008-04-11T23:47:02Z,,0,0,0900006480442000